Identification of HMGCR as the Anticancer Target of Physapubenolide against Melanoma Cells by In Silico Target Prediction

Scientists demonstrated that physapubenolide (PB) inhibited cell proliferation and migration in melanoma cells by inducing cell apoptosis. They explored the mechanism underlying the anticancer effects of PB through an in silico target prediction study.